WPI 50 (Celecoxib 50 mg)

Pill imprint WPI 50 has been identified as Celecoxib 50 mg.

Celecoxib is used in the treatment of osteoarthritis; pain; ankylosing spondylitis; rheumatoid arthritis; spondyloarthritis (and more), and belongs to the drug class cox-2 inhibitors. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Celecoxib

Imprint:

WPI 50

Strength:

50 mg

Color:

Pink & White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Cox-2 inhibitors

Pregnancy Category:

C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation

CSA Schedule:

Not a controlled drug

Manufacturer:

Actavis Pharma, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.